Masullo, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 2.337
EU - Europa 1.884
AS - Asia 1.375
SA - Sud America 365
AF - Africa 43
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.010
Nazione #
US - Stati Uniti d'America 2.295
SG - Singapore 545
CN - Cina 454
DE - Germania 381
SE - Svezia 350
BR - Brasile 336
IT - Italia 266
UA - Ucraina 236
FR - Francia 163
IE - Irlanda 136
FI - Finlandia 91
IN - India 91
ID - Indonesia 86
RU - Federazione Russa 71
GB - Regno Unito 67
VN - Vietnam 43
BD - Bangladesh 27
TR - Turchia 24
CI - Costa d'Avorio 23
PL - Polonia 21
CA - Canada 20
AT - Austria 19
NL - Olanda 18
BE - Belgio 15
ES - Italia 14
KR - Corea 14
MX - Messico 14
HK - Hong Kong 13
IQ - Iraq 11
JP - Giappone 11
PK - Pakistan 10
ZA - Sudafrica 10
UZ - Uzbekistan 7
AR - Argentina 6
EC - Ecuador 6
SA - Arabia Saudita 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
CZ - Repubblica Ceca 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
IR - Iran 4
NP - Nepal 4
RO - Romania 4
AL - Albania 3
CY - Cipro 3
GR - Grecia 3
JM - Giamaica 3
PT - Portogallo 3
TN - Tunisia 3
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
PH - Filippine 2
PY - Paraguay 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
LY - Libia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 6.010
Città #
Chandler 394
Singapore 218
Ashburn 181
Jacksonville 148
Dublin 135
San Mateo 113
Nanjing 89
Jakarta 84
Beijing 68
Ann Arbor 66
Wilmington 59
Dearborn 57
Woodbridge 52
Hefei 45
Lawrence 43
Redwood City 42
Cattolica 41
Munich 40
Boston 39
Marseille 39
Houston 37
Moscow 36
New York 34
Los Angeles 31
Rome 30
São Paulo 30
Seattle 28
Detroit 27
Milan 27
Shenyang 27
Boardman 26
Helsinki 26
Nanchang 26
Princeton 25
Redmond 24
Abidjan 23
Kunming 18
Belo Horizonte 16
Changsha 16
Frankfurt am Main 16
Guangzhou 15
Cambridge 14
Mountain View 14
Nuremberg 14
Seoul 14
University Park 14
Brussels 13
Fairfield 13
Hebei 13
Jiaxing 13
Lancaster 13
Nürnberg 13
San Jose 13
Bremen 12
Chicago 12
North Bergen 12
The Dalles 12
Hangzhou 11
Norwalk 11
Rio de Janeiro 11
Vienna 11
Brooklyn 10
Hanoi 10
Hong Kong 10
London 10
Tianjin 10
Warsaw 10
Zhengzhou 10
Amsterdam 9
Atlanta 9
Ho Chi Minh City 9
Izmir 9
Paris 9
Naples 8
Philadelphia 8
Düsseldorf 7
Kocaeli 7
Renton 7
Santa Clara 7
Tashkent 7
Turku 7
Buffalo 6
Chiari 6
Dallas 6
Dhaka 6
Lanzhou 6
Las Vegas 6
Mexico City 6
Molfetta 6
Stockholm 6
Wroclaw 6
Busto Arsizio 5
Cagliari 5
Casalecchio di Reno 5
Columbus 5
Curitiba 5
Espoo 5
Falkenstein 5
Montreal 5
Porto Alegre 5
Totale 3.022
Nome #
A functional 5HT2A receptor polymorphism (His452Tyr) and memory performances in Alzheimer's disease 156
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 150
Neural substrates of the 'low-level' system for speech articulation: Evidence from primary opercular syndrome 128
EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer’s patients 126
Oxidative Stress And Overexpression Of Manganese Superoxide Dismutase In Patients With Alzheimer's Disease. 120
The complex interaction between APOE promoter and AD: an Italian case-control study 120
R208H-129VV haplotype in the prion protein gene: phenotype and neuroimaging of a patient with genetic Creutzfeldt-Jakob disease. 119
Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease? 116
Neuroradiology of human prion diseases, diagnosis and differential diagnosis. 115
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene 114
Effectiveness of a High-Throughput Genetic Analysis in the Identification of Responders/Non-responders to CYP2D6-Metabolized Drugs 111
New insights into the genetic etiology of Alzheimer's disease and related dementias 111
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 110
APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women 109
Cognitive and behavioral determinants of psychotic symptoms in Alzheimer's disease 104
Different apathy profile in behavioral variant of frontotemporal dementia and Alzheimer's disease: a preliminary investigation 100
Different apathy profile in behavioral variant of frontotemporal dementia and Alzheimer's disease: a preliminary investigation 99
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 98
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 92
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 89
Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin 87
Predicting progression of amnesic MCI: The integration of episodic memory impairment with perfusion SPECT 85
Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study 83
EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer's Disease. 82
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia 82
Possible relationship between Al/ferritin complex and Alzheimer's disease 82
FOXP2, APOE, and PRNP: New Modulators in Primary Progressive Aphasia 81
Predicting progression of amnesic MCI: The integration of episodic memory impairment with perfusion SPECT 81
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 80
The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patients. 79
The genetics of the human APOE polymorphism 78
An atypical phenotype of Creutzfeldt-Jakob Disease(CJD) associated with the E200K mutation in the prion protein gene. 75
Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol 75
Association analysis of GRIN2B, encoding NMDA receptor 2B subunit, and Alzheimer's disease. IF: 2.511 74
Psychotic Symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association 73
Possible relationship between Al/Ferritin complex and Alzheimer's Disesae 73
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 72
Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease 72
The serotonin transporter gene locus in late-life major depressive disorder 72
ApoE-e2/e4 genotype is a risk factor for primary progressive aphasia in women 71
FOXP2, APOE and PRNP new modulators in primary progressive aphasia 71
Rinsing after spinning: plasmapheresis in EBV-related post-infectious cerebellitis 71
Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease 71
The APOE gene locus in FrontoTemporal dementia and Primary Progressive Aphasia 70
Ixekizumab exposure associated with myelitis: A case report and a literature review 70
TOMM40, APOE and APOC1 in primary progressive aphasia and Frontotemporal dementia 69
Polymorphism C in the serotonin 1 transporter gene in depression-free elderly patients with vascular dementia 66
Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's Disease ? 64
APOE ε2-ε4 genotype is a possible risk factor for primary progressive aphasia [6] 64
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease 63
Survival in Alzheimer s disease is shorter in women carrying heterozigosity at codon 129 of the PRNP gene and no APOE e4 allele. IF: 2.511 63
The complex interaction between APOE promoter and AD. An Italian case-control study. 62
Selective impairment of living things and musical instruments on a verbal 'Semantic Knowledge Questionnaire' in a case of apperceptive visual agnosia 61
Codon 129 polymorphism of prion protein gene in sporadic Alzheimer s disease. IF: 2.437 60
Apolipoprotein E ε4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients 59
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 58
BuChE K-variant is decreased in Alzheimer's disease not in Fronto-Temporal Dementia 57
Top-Down Proteomics of Human Saliva Highlights Anti-inflammatory, Antioxidant, and Antimicrobial Defense Responses in Alzheimer Disease 56
Seripa D, Matera MG, Daniele A, Bizzarro A, Rinaldi M, Gravina C, Bisceglia L, Corbo RM, Panza F, Solfrizzi V, Fazio VM, Dal Forno G, Masullo C, Dallapiccola B, Pilotto A. The mssing ApoE allele. Annals of Human Genetics. published online 22 January 2007; doi: 10.111/j.1469-1809.2006.00344x. IF=3.19 56
Acute administration of individual optimal dose of physostigmine fails to improve mnesic performances in Alzheimers Presenile Dementia 56
The missing ApoE allele 55
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 53
The RELN locus in Alzheimer's Disease 53
Sensing red blood cell nano-mechanics: Toward a novel blood biomarker for Alzheimer’s disease 52
Characterization of Cystatin B Interactome in Saliva from Healthy Elderly and Alzheimer’s Disease Patients 51
Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism 51
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease 50
Alzheimer's Disease:fatty acids we eat may be linked to a specific protection via low-dose aspirin 50
Different apathy profile in behavioral variant of frontotemporal dementia and Alzheimer's disease: a preliminary investigation. 49
Genotypes and haplotypes in the IL-1 gene cluster: Analysis of two genetically and diagnostically distinct groups of Alzheimer patients 49
Allelic distribution of apolipoprotein E (ApoE) and ApoE promoter polymorphisms in patients with frontotemporal dementia. 46
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes 44
Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients 42
Analysis of allelic distribution of ApoE promoter polymorphism: relation to gender, age at onset, and var epsilon epsilon 4 in a sample of sporardic AD patients. 41
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease 40
Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation 40
X‐chromosome-wide association study for Alzheimer’s disease 34
Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease 31
A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls 29
Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging 28
Apolierotein E genotype in sporadic early - and late - onset alzheimer's Disease 28
Apoe epsilon2-epsilon4 genotype is a possible risk factor for prymary progressive aphasia 28
Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls 25
The influence of apolipoprotein E ε4 allele on cognitive performance in early stages of Alzheimer's disease 22
The apoliprotein E genotype in patients affected by syndromes with Focal Cortical Atrophy 17
The apolipoprotein E genotype in patient affected by syndromes with focal cortical atrophy 11
Totale 6.130
Categoria #
all - tutte 30.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021493 0 47 23 45 64 26 85 9 66 44 71 13
2021/2022525 53 56 11 21 25 17 11 93 24 23 94 97
2022/20231.177 151 155 85 149 117 137 78 78 154 25 27 21
2023/2024538 27 194 24 27 14 41 22 34 3 23 57 72
2024/20251.337 29 34 103 48 94 43 20 69 240 119 306 232
2025/2026583 552 31 0 0 0 0 0 0 0 0 0 0
Totale 6.130